The domestic passenger traffic at Goa Airport is getting back to normal as the facility has recorded about 75 percent footfalls so far this year compared to the same period last year during pre-COVID-19 times, a senior official said on Sunday.
Talking to PTI, Goa Airport's Director Gagan Malik said the number of domestic flights are also increasing amid the unlock process, even as scheduled and chartered international travel continues to remain suspended. After the lockdown in March this year due to the pandemic, India resumed its scheduled domestic passenger flights from May 25.
Malik said since the Goa Airport reopened for domestic travel, the passenger flow has returned to 70-75 percent now compared to last year, and is expected to pick up further next month, which is the peak tourist season in the state. "The domestic passenger footfalls are expected to cross 80 percent in December," he said.
On an average, 11,000 passengers arrive and depart from the Goa Airport on weekdays, while on weekends, the number reaches about 13,500, the official said. Goa has been witnessing an inflow of visitors as hotels, restaurants and other places of tourist interests have opened up as part of the unlock process.
Malik said 50 percent of the domestic flights have resumed, and are likely to go up to 60-65 percent next month. Besides reactivating older routes, airlines have also connected new routes like Lucknow, Nagpur, Chandigarh during the unlock phase, he said.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.